Buyout PE
Harwood Private Equity
Harwood Private Equity acquires controlling stakes in established, profitable businesses, from London, United Kingdom. It states a focus on healthcare & life sciences, consumer & retail and industrials & manufacturing.
Stated investment criteria
What Harwood Private Equity says it buys
Read from Harwood Private Equity’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Harwood Private Equity to consider any particular business, and nothing on this page is represented as being for sale.
SEC filings
What Harwood Private Equity has raised
From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.
| Vehicles filed | 3 |
| Total capital raised | $238m |
| Largest single vehicle | $234m |
| Filing history | 2014 to 2022 |
| Smallest accepted commitment | $39k |
| Filed from | UNITED KINGDOM |
Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.
Regulatory record
How Harwood Private Equity is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | SEC registered |
| Regulatory assets under management | $53m |
| Employees | 8 |
| SEC adviser number | CRD 330340 |
Portfolio
Disclosed holdings
Companies Harwood Private Equity lists on its own website. 2 carry a stated investment year.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| Tissue Regenix | 2025 | 1 | — |
| Frenkel Topping | 2026 | 0 | — |
| 3bl Media | — | — | — |
| APC Technology Group PLC | — | — | — |
| Amito | — | — | — |
| Assisi | — | — | — |
| Bionostics | — | — | — |
| Celsis | — | — | — |
| CoventBridge Fund 4 Invested: March 2016 | — | — | — |
| Crest Foods | — | — | — |
| Curtis Gilmour | — | — | — |
| Cyprotex | — | — | — |
| Groupe Chez Gerard | — | — | — |
| Hml | — | — | — |
| Inspecs | — | — | — |
| Inspired Gaming Group | — | — | — |
| Journey | — | — | — |
| Lindley Catering | — | — | — |
| Medica | — | — | — |
| Motherwell Bridge | — | — | — |
| Mr Fothergills | — | — | — |
| OpenBet | — | — | — |
| Orthoproducts | — | — | — |
| Pelsis | — | — | — |
| Quickline | — | — | — |
| Smt Corporation | — | — | — |
| Source Bioscience | — | — | — |
| Source Bioscience International | — | — | — |
| WaterBox Fund 5 Invested: December 2021 | — | — | — |
Compiled from Harwood Private Equity’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Recorded transactions
Buying and selling
Deals in which Harwood Private Equity is named as buyer or seller in the transaction archive. 2 recorded acquisitions.
| Company | Side | Counterparty | Year | Consideration |
|---|---|---|---|---|
| HML Holdings | Bought | — | 2020 | $29m |
| Air Fayre | Bought | — | 2016 | $49m |
Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Harwood Private Equity?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other buyout pe investors active in healthcare & life sciences.